The purpose of this study is to determine whether the addition of an investigational drug called LY3537982 to the current standard-of-care treatment (immunotherapy +/- chemotherapy) helps control cancer for a longer period of time and ...
This study focuses on people who have been diagnosed with rhabdomyosarcoma (RMS), a type of cancer that occurs in the soft tissues of the body and whose cancer is considered low-risk (LR-RMS). The purpose of ...
Primary:
1. To compare rate of minimal residual disease (MRD) negative second remission (Rem-2, see definition in Section 3.3.3) after up to two cycles of Reinduction with blinatumomab vs. blinatumomab/nivolumab in Group 1 patients aged ? ...
The purpose of this study is to compare 2 radiation schedules that can be used to treat patients with high-risk prostate cancer. One approach delivers a higher dose of radiation per treatment and uses fewer ...
The purpose of this study is to determine whether an over-the-counter nutritional supplement called Urolithin A changes the biological composition of the prostate in a favorable direction in patients with prostate cancer who are scheduled ...
